a Vigibase Pharmacovigilance Study of ENzalutamide Drug-induced neurotoxicitY

计划入组 500,000 人 · 首次发布于 2020 年 3 月 2 日

Adverse Drug Reactions in Pediatrics: Experience of a Regional Pharmacovigilance Center

计划入组 632 人 · 首次发布于 2017 年 10 月 20 日

Active Pharmacovigilance of Anti-cancer Medicines

计划入组 50 人 · 首次发布于 2023 年 4 月 24 日

drug candidate

undisclosed drug

repurposed drug

MSA Safety

Egypt

PARAMOUNT SAFETY PRODUCTS (NZ) LIMITED

New Zealand

Redpharm Drug

United States

Amgen's Strategic Approach to Global Pharmacovigilance: Balancing Innovation with Patient Safety

Drug Safety Experts Call for Enhanced Diagnostic Accuracy in Clinical Trials to Protect Patient Safety

Parexel Acquires AI-Powered Pharmacovigilance Platform Vitrana to Enhance Patient Safety Technology